Literature DB >> 10580843

The inducible cyclic adenosine monophosphate early repressor (ICER) in the pituitary intermediate lobe: role in the stress response.

C Mazzucchelli1, P Sassone-Corsi.   

Abstract

The cAMP signalling pathway plays a key role in the regulation of the hypothalamic-pituitary-adrenal axis. Transcription factor CREM (cAMP response element modulator) is implicated in the modulation of a number of neuroendocrine functions. By virtue of an alternative, intronic promoter CREM generates the powerful transcriptional repressor ICER (inducible cAMP early repressor), which displays a pronounced neuroendocrine-specific expression. Here we document a remarkable induction of ICER in response to acute stress in the intermediate lobe (IL) of the pituitary gland. The induction is transient and is preceded by CREB phosphorylation. Adrenergic stimulation directs ICER induction in the IL through the activation of both beta2-adrenergic and corticotrophin-releasing hormone receptors. These receptors are positively coupled to the adenylate cyclase signalling pathway, which regulates hormone release from the IL, implicating ICER in the modulation of peptide secretion. We show that targeted ablation of the CREM gene in the mouse causes a chronic increase of beta-endorphin levels. Altered hormonal production occurs both in basal conditions and after stress. Thus, early ICER induction in the IL may be involved in the modulation of gene expression in response to stress.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580843     DOI: 10.1016/s0303-7207(99)00103-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  2 in total

Review 1.  Inducible cAMP early repressor (ICER) and brain functions.

Authors:  Gilyana Borlikova; Shogo Endo
Journal:  Mol Neurobiol       Date:  2009-05-13       Impact factor: 5.590

Review 2.  Decompensation of β-cells in diabetes: when pancreatic β-cells are on ICE(R).

Authors:  Roberto Salvi; Amar Abderrahmani
Journal:  J Diabetes Res       Date:  2014-02-10       Impact factor: 4.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.